Skip to main content
logo
Waverley Pharma Inc. (TSXV:WAVE)
Canada flag Canada · Delayed Price · Currency is CAD
0.0150
0.00 (0.00%)
At close: Sep 15, 2026

Waverley Pharma Ratios and Metrics

Millions CAD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
111124
Market Cap Growth
0%100.00%-60.00%-16.67%-62.50%-36.00%
Enterprise Value
443224
Last Close Price
0.010.020.010.030.030.08

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
0.690.801.143.281.302.47
PB Ratio
-0.28-0.42-0.27-1.191.492.42
P/TBV Ratio
-----139.88

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
3.723.146.865.961.602.41

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
-1.26-1.34-1.51-1.410.640.15
Net Debt / Equity Ratio
-1.25-1.32-1.39-1.360.520.06
Net Debt / EBITDA Ratio
-7.07-11.66-3.35-1.61-0.69-0.14
Asset Turnover
0.940.820.320.230.390.49
Inventory Turnover
3.052.951.9910.694.925.14
Quick Ratio
0.020.020.120.090.210.45
Current Ratio
0.090.120.190.200.400.76
Return on Equity (ROE)
-----46.11%-41.57%
Return on Assets (ROA)
-28.13%-13.27%-35.94%-44.06%-18.37%-13.71%
Return on Capital Employed (ROCE)
20.90%14.60%47.60%112.90%-85.80%-44.00%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-91.91%-46.22%-175.38%-164.74%-40.99%-18.44%